masivet
ab science s.a. - masitinib mesilate - antineoplastic agents - dogs - treatment of non-resectable dog mast-cell tumours (grade 2 or 3) with confirmed mutated c-kit tyrosine-kinase receptor.
masipro
ab science - masitinib mesilate - mastocytosis - antineoplastic agents - treatment of mastocytosis
alsitek
ab science - masitinib mesilate - amyotrophic lateral sclerosis - antineoplastic agents - treatment of amyotrophic lateral sclerosis.
masiviera
ab science - masitinib - pancreatic neoplasms - protein kinase inhibitors - treatment of non resectable locally advanced or metastatic pancreatic cancer
masican
masitinib - gastrointestinal stromal tumors - l01xe - treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist),
masican
masitinib - gastrointestinal stromal tumors - l01xe - treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist),
masivet 150 mg film-coated tablets for dogs
ab science - masitinib - tablet - anti neoplastic agent - dogs
masivet 50 mg film-coated tablets for dogs
ab science - masitinib - film-coated tablet - anti neoplastic agent - dogs